16:34 , Apr 14, 2017 |  BC Week In Review  |  Company News

Cellular Biomedicine, GE deal

Cellular Biomedicine and the GE Healthcare Life Science China unit of General Electric Co. partnered to jointly develop automated systems for manufacturing chimeric antigen receptor T cell and stem cell therapies. The partners said the...
20:38 , Apr 11, 2017 |  BC Extra  |  Company News

Cellular Biomedicine, GE in China cell manufacturing deal

Cellular Biomedicine Group Inc. (NASDAQ:CBMG) said it partnered with the GE Healthcare Life Science China unit of General Electric Co. (NYSE:GE) to jointly develop automated systems for manufacturing chimeric antigen receptor T cell and stem...
00:36 , Mar 10, 2017 |  BC Week In Review  |  Company News

CIRM funding news

CIRM awarded $32.6 million in grants to fund clinical trials and R&D. Caladrius will receive up to $12.2 million for its ongoing Phase II trial of autologous T regulatory cells ( CLBS03 ) to treat...